TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer February 25, 2011
TCL Archive In Brief: NIH Intramural Research Said Needing Better Peer Review, Change In Selecting Counselors April 23, 1976
TCL Archive DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money August 31, 1979
TCL Archive In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan. March 12, 2004
